Risk factor profile and the occurrence of microvascular complications in short term type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi

East African Medical Journal

Volumn 82, Issue 12 SUPPL., 2005, Pages

  Mwendwa, F M ^a   Otieno, C F ^b   Kayima, J K ^b   Amayo, E O ^b   Otieno, P O ^c  

^a Upper Hill Medical Centre   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; KENYA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIA; KENYA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 33644593235     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. King, H. and Rewers, M. On behalf of the WHO Ad Hoc Diabetes reporting group. Diabetes in adults is now a third world problem. Bull. World Health Org. 1991; 15: 232-252.
2. Haffner S.M. Cardiovascular risk factors and the prediabetic syndrome. Ann. Med. 1996; 28: 363-370.
3. UKPDS group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853
4. Estacio, R.O., Gifford, N., Jaffers, B.W. et al. Effect of blood pressure control on diabetic microvascular complications in patients with NIDDM and Hypertension. Diabetes Care. 2000; 23 (Suppl 2): B54-B64
5. Baynes, J.W. and Thorpe, S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999; 48: 1-9
6. The DCCT Research group. Diabetes: clustering of long-term complications in families with diabetes in the DCCT. Diabetes. 1997; 46: 1829-1839.
7. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complication. Report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Geneva, Switzerland: World Health Organization; 1999.
8. Xavier Pi-Sunyer F. Obesity. In: Bennett, J.C., Plum, F. (eds). Cecil Textbook of Medicine. Philadelphia, WB Saunders Co. 1996; 1161-67.
9. World Health Organisation. Obesity: preventing and managing the global epidemic of obesity. Report of the WHO Consultation of Obesity. Geneva, Switzerland, June 3-5, 1997.
10. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch. Intern. Med. 1997; 157: 2413-2446.
11. Macleod, A. and Sonsken, P. Diabetic Neuropathy. In: Shaw KM. Diabetic complications. John Wiley and Sons Ltd. 1996; pp. 123-148.
12. Dyck, P.J., Karnes, J.L., Daube, J. et al. Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain. 1985; 108: 861-880.
13. Dyck, P.J., Kratz, K.M., Lehman, K.A., Karnes, J.L. et al. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias and reproducibility of neuropathic tests. Neurology. 1991; 41: 799-807.
14. Swash, M. Autonomic function. In: Hutchinson's Clinical Methods. 19th Ed. Balliarre Tindall, London. 1989: 366.
15. Bannister, K.M. and Field, M.F. Clinical physiology of the Kidney: tests of renal function and structure. In: Weatherall, D.J., Ledingham, J.G.G., Warrel, D.A. (eds) Oxford Textbook of Medicine. 3rd Ed. Oxford University Press. 1996; 3: 3106-3107.
16. Friedewald, W.T., Levy, R. and Fredricksons, D.S. Estimation of LDL cholesterol in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
17. Expert panel on the detection, evaluation and treatment of high cholesterol in adults: Summary of the second report of the National Cholesterol Education Programme (NCEP). JAMA. 1993; 269: 3015-3023.
18. ADA Management of dyslipidaemia in adults with diabetes. Diabetes Care. 2002; 25: 574-577.
19. Harris, M.I. et al. Onset of diabetes occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992; 15: 815-819.
20. King, H., Aubert, R.E. and Herman, W.H. Global burden of diabetes mellitus. 1995-2005. Prevalence, reviewed estimates and projections. Diabetes Care. 1996; 9: 1414-1422.
21. Davis, M.E.T., Stratton, I.M., Fox, J.C., Holmann, R.R. UKPDS 22. Effect of age at diagnosis on diabetic tissue damage during the first six years of NIDDM. Diabetes Care. 1997; 20: 1435-1441.
22. Omar, M.A.K., Seedat, M.A., Dyer, R.B. et al. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care. 1994; 1: 70-73.
23. Wingard, D.L. and Barrett-Connor, E. Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic and diabetic adults. Amer. J. Epidemiol. 1987; 125: 948-958.
24. Vaag, A. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Dan. Med. Bull. 1999; 46: 197-234.
25. Haas, T., Sracina, S., Pav, J. et al. Risk calculation of type 2 diabetes. Comput Methods Programs Biomed. 1994; 41: 297-303 (Abstract).
26. Knowler, W.C., Pettitt, D.J., Savage, P.J. and Bennett P.H. Diabetes incidence in Pima Indians. Contributions of obesity and parenteral diabetes. Amer. J. Epidemiol. 1981; 113: 144-156.
27. Haffner, S.M., Stern, M.P., Hazuda, H.P. et al. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA. 1990; 21: 2893-2898.
28. Celermajer, D.S. et al. Cigarette-smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation. 1993; 88: 2149-2155.
29. Pascot, A., Despres, J.P., Lemieux, I. et al. Deterioration of the metabolic risk profile in women: respective contributions of impaired glucose tolerance and visceral fat accumulation. Diabetes Care. 2001; 24: 902-908.
30. Nyamu P.M., Otieno C.F., Amayo E.O. and McLigeyo S.O. Patterns of Diabetic foot ulcers at Kenyatta National Hospital. East Afr. Med. J. 2003; 80: 36-43.
31. Goyder, E.C. and Irwig, L.M. Screening for type 2 diabetes mellitus: a decision analytic approach b. Diabetic Med. 2000; 17: 469-477.
32. Betteridge, D.J. Diabetic dyslipidemia - what does it mean? Review. Diabetes News. 1997; 18: 1-3.
33. Cook, C.B., Erdman, D.M., Ryan, G.J. et al. The pattern of dyslipidemia among urban African Americans with type 2 diabetes. Diabetes Care. 2000; 23: 319-324.
34. Dorf, A., Ballantine, E.J., Bennett, P.H., Miller, M. and Phoenix. Retinopathy in Pima Indians: Relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes. 1976; 25: 554-560.
35. Otim, M.A. Preliminary observations on diabetic retinopathy in Ugandan Africans attending Mulago diabetic clinic. East Afr. Med. J. 1975; 52: 63-70.
36. Erasmus, R.T., Alanamu, R.A., Bojuwoye, B. et al. Diabetic retinopathy in Nigerians: Relation to duration of diabetes, type of treatment and degree of control. East Afr. Med. J. 1989; 66: 248-253.
37. Mhando, P.A. and Yudkin, J.S. The pattern of diabetic complications in African patients in Dar es Salaam. Trop. Geogr. Med. 1980; 32: 317-323.
38. Knowler, W.C., Bennett, P.H. and Ballantine, E.J. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N. Engl. J. Med. 1980; 302: 645-650.
39. Schumacher, M.C. and Smith, K.R. Diabetes in Utah among adults: Interaction between diabetes and other risk factors for microvascular and macrovascular complications. Amer. J. Public Health. 1988; 78: 1195-1201.
40. Giacca, A., Caviezel, F., Pozza, G. and Radorelli, G. Risk factors for retinopathy in 458 diabetics. Microvascular and Neurological Complications of Diabetes. Liviana Press. Fidia Research Series. 1987; 10: 85-90.
41. Aiello, L.P., Gardner, T.W., King, G.L. et al. Diabetic retinopathy. Diabetes Care. 1998; 21: 143-156.
42. Klein, R., Klein, D.E.K., Moss, S.E. et al. The Wisconsin epidemiological study of diabetic retinopathy III. Prevalence and risk of retinopathy when age at diagnosis is 30 years or more. Arch. Ophthalmol. 1984; 102: 527-532.
43. Gall, M-A., Rossing, P., Skott, P. et al. Prevalence of micro- and macro-albuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 diabetic patients. Diabetologia. 1991; 34: 655-661.
44. Steel et al. Diabetic retinopathy in Kenya. Trop. Doctor. 1997.
45. Ryder, R. E. J. Screening for diabetic retinopathy. Brit. Med. J. 1995; 311: 207-208.
46. Owens, D.R., Gibbins, R.L., Lewis, P.A. et al. Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35mm colour transparencies? Diabet. Med. 1998; 15: 170-175.
47. O'Hare, J.P., Hopper, A., Madhaven, C. et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. Brit. Med. J. 1996; 312: 679-682.
48. Buxton, M.J., Sculpher, M.J. and Fergusen, B.A. Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet. Med. 1991; 8: 371-377.
49. Lienert, R.T. Inter-observer comparisons of ophthalmoscopic assessment of diabetic retinopathy. NZJ Ophthal. 1989; 17: 363-368.
50. Wanjohi, F.M., Otieno, C.F., Ogola, E.N. and Amayo, E.O. Nephropathy in black African with short-term type 2 diabetes mellitus in Nairobi, Kenya. East Afr. Med. J. 2002; 79: 399-404.
51. Deckert, T., Feldt-Rasmussen, B., Borsch-Johnsen, K. et al. Albuminuria reflects widespread vascular damage: The Steno hypothesis Diabetologia. 1989; 32: 219-226.
52. Marshall, S.M. and Alberti, K.G.M.M. Comparison of the prevalence and associated features of abnormal excretion in insulin-dependent and non-insulin dependent diabetes. Quart. J. Med. 1989; 261: 61-71.
53. Schmitz, A. and Vaeth, M. Microalbuminuria: a major risk factor in type 2 diabetes. A 10-year follow-up of 503 patients. Diabetic Med. 1988; 5: 126-134.
54. Pfeiffer, M.A. and Weinberg, C.R. Differential changes of autonomic nervous system function with age in man. Amer. J. Med. 1983; 75: 249-257.
55. Abbas, Z.G. and Swai, A.B.M. Evaluation of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr. Med. J. 1997; 12: 803-808.
56. Saito, N., Kimura, M., Kuhiba, A. and Itokkawa, Y. Blood thiamine levels in outpatients with diabetes mellitus. J. Nutr. Sci. Vitaminol. 1987; 33: 421-430 (Abstract).
57. The DCCT research Group. Factors in the development of diabetic neuropathy in the feasibility phase of DCCT. Diabetes. 1988; 37: 476-481.
58. Franklin, G.M., Kahn, L.B., Baxter, J. et al. Sensory neuropathy in non-insulin dependent diabetes mellitus. The San Luis Valley Diabetes Study. Amer. J. Epidemiol. 1990; 4: 633-643.
59. Pickett, J.B. Motor conduction velocity - faster in women. Diabetologia. 1982; 23: 544-548.
60. Chokwe, T.M. Cardiac autonomic neuropathy in patients with diabetes mellitus in the outpatient diabetic clinic at the Kenyatta National Hospital. Master of Medicine, 2000. Department of Anaesthesia, University of Nairobi.
61. Straube, R.H., Zietz, B. and Palitzsch, K.D. Scolmerich. Impact of disease duration on cardiovascular and papillary autonomic nervous function in IDDM and NIDDM. Diabetes Care. 1996; 9: 960-967.